30
Apr
2008
Insmed (Nasdaq: INSM) provided a status update on their development program. After recently receiving approval form the UK Medicines and Healthcare Regulatory Agency to initiate a clinical trial for INS-19 [a follow-on biologic of Amgen’s (Nasdaq: AMGN) Neupogen®] patient screening has begun and the first dosing is expected next month with similarity data to be [...]
30
Apr
2008
Bard Center Needs Your Help!
Posted in My Rants
Two MBA students at the University of Colorado, Bard Center for Entrepreneurship are examining how their institution may better support the Colorado life science ecosystem via the delivery of specifically tailored graduate degrees, certificates and continuing education offerings that may ultimately empower, improve and expand the local workforce. Kindly set aside five minutes of your [...]
29
Apr
2008
The Technology Transfer Office at the University of Colorado is seeking an entry-level Life Sciences Licensing Associate for its office at the Anschutz Medical Campus. The License Associate identifies, solicits, and evaluates invention disclosures for patent and market potential, and marketing technologies to commercial partners and tracks and develops a portfolio of associated intellectual property. [...]
27
Apr
2008
Evolutionary Genomics (Lafayette) an agricultural technology company who addresses the critical need to increase the availability of biofuel feedstocks has closed an undisclosed Series A financing with Denver-based Altira Group; not to be confused with the Altria Group or its much better known previous name Philip Morris (NYSE: MO). EG’s Adapted Traits Platform is used [...]
27
Apr
2008
SBIR/STTR Bill Passes in House
Posted in My Rants
Lest you think the Colorado Bioscience Association merely flexes its muscle in Colorado…think again. Denise Brown and Company weighed in with significant support on Capital Hill re: HR5819 or the SBIR/STTR Reauthorization Act, which passed in the U.S. House of Representatives by a vote of 369 to 43. All Colorado Representatives (Diana DeGette, Mark Udall, [...]
24
Apr
2008
It has been quite a journey for House Bill 08-1001 and today was graduation day; the Bill became law with the stroke of Governor Ritter’s pen!!! HB08-1001 a $26.5M package, sponsored by Rep. Jim Riesberg, (D-Greeley), and Sen. Bob Bacon, (D-Fort Collins), provides grants for five years to Colorado start-up companies and research institutions seeking [...]
23
Apr
2008
It is never a good feeling to wake up and hear that a pivotal late-stage clinical trial has terminated enrollment. However, there is a silver lining in such a difficult decision cloud…that is the sophisticated management at Replidyne (NASDAQ: RDYN) are savvy enough to examine the risk-reward profile for the continued burn of their remaining [...]
22
Apr
2008
Allos Therapeutics (NASDAQ: ALTH) has completed patient enrollment a quarter ahead of schedule for their Phase II trial of PDX (pralatrexate) in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).The pivotal Phase II trial is an international, multi-center, open-label, single-arm study that enrolled patients with relapsed or refractory PTCL who progressed after at least [...]
20
Apr
2008
BioBeers is locked and loaded for Tuesday 29 April at our new start time of 6:00pm, enabling even more networking time over the malts and hops; BioBeers is working overtime for you! Now there has been some debate about where to hold this months’ BioBeers, so we elected to settle the question the democratic way [...]
18
Apr
2008
An important milestone for Insmed (NASDAQ: INSM), developer of follow-on biologics and biopharmaceuticals, was achieved in the form of approval from the UK’s Medicines and Healthcare products Regulatory Agency to initiate their first clinical study for INS-19, a follow-on biologic product candidate. INS-19, is a recombinant form of human G-CSF, is a follow-on biologic of [...]
17
Apr
2008
Corgenix Medical Corporation (NASDAQ: CONX.OB) received 510(k) clearance by the FDA for their IgG Anti-AtherOx® Test Kit. This new laboratory test detects antibodies in individuals with important autoimmune diseases such as systemic lupus erythematosus and other and lupus-like disorders. The AtherOx® technology utilizes oxidized low-density-lipoprotein (oxLDL) complexed with the plasma protein B2GPI. Although oxLDL has [...]
17
Apr
2008
Accelr8 and Becton Dickinson Agree to Terms
Posted in CO Pub Rel: Becton Dickinson, CO Public: Accelr8
Accelr8 Technology Corporation (AMEX:AXK) announced an agreement with Becton, Dickinson (NYSE: BDX) for the BACcel™ rapid bacterial diagnostic system. Becton will fund an 18-month milestone-based project which includes the option to license the technology for product development, manufacturing and, commercialization use for the clinical diagnosis of infectious diseases. BACcel™ rapid diagnostic system may deliver bacterial [...]
16
Apr
2008
Biz-Plan Competition Feedback
Posted in My Rants
Friends Maggie Popesco, Ph.D. and Eric Hoffman, MS are students at the University of Colorado Denver Business School and have entered the Bard Center for Entrepreneurship Business Plan Competition. They are developing a business plan around a company (Evolve Biosciences) which will target non-therapeutic biotechnology, medical device, and diagnostic IP developed at Colorado universities. Currently, [...]
Life Science Deal Flow PARTNERS
-
